122 related articles for article (PubMed ID: 59332)
21. Combination of cis-platinum, oncovin, and bleomycin (COB) prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck.
Peppard SB; Al-Sarraf M; Powers WE; Loh JK; Weaver AW
Laryngoscope; 1980 Aug; 90(8 Pt 1):1273-80. PubMed ID: 6157067
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacology of bleomycin and cisplatin.
Evans WE; Yee GC; Crom WR; Pratt CB; Green AA
Drug Intell Clin Pharm; 1982 Jun; 16(6):448-58. PubMed ID: 6178575
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
Schröder M; von Heyden HW; Beyer JH; Klee M
Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831
[TBL] [Abstract][Full Text] [Related]
24. [Combination chemotherapy with cis-diammine-di-chloro-platinum (II) and bleomycin in advanced head and neck cancer].
Sasaki T; Ibuka T; Imai K; Sakai Y; Hayakawa M; Tanikawa Y; Miyashita H; Komiya Y; Matsuda T
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1412-7. PubMed ID: 6191715
[TBL] [Abstract][Full Text] [Related]
25. The place of bleomycin in the treatment of highly differentiated squamous cell cancer either alone or in combination with irradiation.
Rygård J; Hansen HS
Prog Biochem Pharmacol; 1976; 11():205-18. PubMed ID: 63966
[No Abstract] [Full Text] [Related]
26. [Treatment of disseminated oro-pharyngo-laryngeal epidermoid carcinomas with a combination of methotrexate and bleomycine in small doses].
Medenica R; Alberto P; Lehmann W
Schweiz Med Wochenschr; 1976 Jun; 106(23):799-802. PubMed ID: 63144
[TBL] [Abstract][Full Text] [Related]
27. Combined radiotherapy and bleomycin for advanced head and neck cancers: results of a phase I pilot study.
Silverberg IJ; Phillips TL; Fu KK; Chan PY
Cancer Treat Rep; 1981; 65(7-8):697-8. PubMed ID: 6166375
[TBL] [Abstract][Full Text] [Related]
28. Bleomycin (NSC-125066) therapy of responsive solid tumors.
Durkin WJ; Pugh RP; Jacobs E; Sadoff L; Pajak T; Bateman JR
Oncology; 1976; 33(5-6):260-4. PubMed ID: 68454
[TBL] [Abstract][Full Text] [Related]
29. Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease.
Muggia FM; Rozencweig M; Louie AE
Head Neck Surg; 1980; 2(3):196-205. PubMed ID: 6153379
[TBL] [Abstract][Full Text] [Related]
30. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
Ervin TJ; Weichselbaum R; Miller D; Meshad M; Posner M; Fabian R
Cancer Treat Rep; 1981; 65(9-10):787-91. PubMed ID: 6168371
[TBL] [Abstract][Full Text] [Related]
31. [Results of several times daily treatment by cisdiamine-platinum and bleomycin. Therapeutical considerations (author's transl)].
Soudant J; Israel L; Aguilera J; Breau JL; Frachet B; Strunski V
Ann Otolaryngol Chir Cervicofac; 1982; 99(1-2):61-5. PubMed ID: 6179450
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
Pouillart P; Palangie T; Garcia-Giralt E; Jouve M; Bataini JP; Jaulerry M; Brugère J; Asselin B
Bull Cancer; 1980; 67(3):269-80. PubMed ID: 6157447
[TBL] [Abstract][Full Text] [Related]
33. Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.
Haines I; Bosl G; Pfister D; Spiro R; Gerold F; Sessions R; Shah J; Strong E; Vikram B; Harrison L
J Clin Oncol; 1987 Oct; 5(10):1594-600. PubMed ID: 2443621
[TBL] [Abstract][Full Text] [Related]
34. Effective outpatient combination chemotherapy for advanced cancer of the head and neck.
Chiuten D; Vogl SE; Kaplan BH; Greenwald E
Surg Gynecol Obstet; 1980 Nov; 151(5):659-62. PubMed ID: 6159692
[TBL] [Abstract][Full Text] [Related]
35. [Preliminary results of a chemotherapy study of patients with squamous cell carcinoma in the head and neck region. Comparison of 2 therapeutic regimens: cis-diamminodichloroplatinum (II) and bleomycin compared to methotrexate and vindesine].
von Heyden HW; Beyer JH; Matthaei A; Nagel GA; Schröder M
Onkologie; 1981 Dec; 4(6):296-9. PubMed ID: 6175933
[TBL] [Abstract][Full Text] [Related]
36. Hematologic effects of cis-platinum-bleomycin therapy.
Najarian T; Miller A; Zimelman AP; Ki Hong W
Oncology; 1981; 38(4):195-7. PubMed ID: 6165944
[TBL] [Abstract][Full Text] [Related]
37. Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients.
van der Schoot GGF; Westerink NL; Lubberts S; Nuver J; Zwart N; Walenkamp AME; Wempe JB; Meijer C; Gietema JA
Eur J Cancer; 2016 May; 59():134-141. PubMed ID: 27033261
[TBL] [Abstract][Full Text] [Related]
38. [New experiences with bleomycin].
Wespi H
ORL J Otorhinolaryngol Relat Spec; 1976; 38 Suppl 1():104-7. PubMed ID: 63931
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
Kelsen DP; Bains M; Chapman R; Golbey R
Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
[TBL] [Abstract][Full Text] [Related]
40. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
King GW; Halpin JJ; Smith RE; Batley F; Schuller DE
Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
